iBio (FastPharming / iBio CDMO LLC)
Bryan, TX (historic CDMO facility); current corporate pivot to San Diego, CA
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: iBio (FastPharming / iBio CDMO LLC)
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Bryan, TX (historic CDMO facility); current corporate pivot to San Diego, CA
- Modalities
- Plant-Derived Biologics (Nicotiana benthamiana, transient expression), Monoclonal Antibodies, Vaccines / VLPs, Recombinant Proteins (including lysosomal enzymes, cytokines, blood factors), GMP FastPharming cGMP Manufacturing, Aseptic Fill/Finish
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About iBio (FastPharming / iBio CDMO LLC)
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesPlant-Derived Biologics (Nicotiana benthamiana, transient expression), Monoclonal Antibodies, Vaccines / VLPs, Recombinant Proteins (including lysosomal enzymes, cytokines, blood factors), GMP FastPharming cGMP Manufacturing, Aseptic Fill/Finish
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (6 modalities)
Frequently Asked Questions About iBio (FastPharming / iBio CDMO LLC)
What is iBio (FastPharming / iBio CDMO LLC)'s CDMO Signal Score?
iBio (FastPharming / iBio CDMO LLC) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating iBio (FastPharming / iBio CDMO LLC) for a manufacturing program?
Use the free AI matchmaker to compare iBio (FastPharming / iBio CDMO LLC) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Kentucky Bioprocessing (KBP)
Owensboro, KY
Plant-Derived Biologics (Nicotiana benthamiana), Monoclonal Antibodies, Vaccines / VLPs, Recombinant Proteins, GMP Plant-Made Pharmaceuticals (PMP)
Argonaut Manufacturing Services
Carlsbad, CA
Aseptic Fill/Finish, Biologics (injectable), mAbs, Peptides, Small Molecules, Vaccines, IVD/Diagnostics, Lyophilization
IDT Biologika GmbH
Dessau-Roßlau, Germany
Viral Vaccines (live, inactivated, BSL-2), AAV, Adenoviral Vectors, Lentiviral Vectors, Gene & Immune Therapeutics, Oncolytic Viruses, Monoclonal Antibodies, Recombinant Proteins / Biosimilars, Sterile Fill-Finish (liquid, lyophilized, vials, pre-filled syringes)